News
HSA Adverse Drug Reaction News 2020 Dec, Vol.22 No.3
Professionals
Allied Health Professionals
Dental Practitioners
Doctors
Nurses
Pharmacists
TCM Practitioners
15 December 2020
Access and read HSA's December 2020 bulletin which covers adverse events for health products and other news.
HSA Adverse Drug Reaction News 2020 Dec, Vol.22 No.3
The aim of the news bulletin is to increase the awareness of adverse events related to health products amongst healthcare professionals, and to promote adverse event reporting related to health products.
This issue includes the following topics:
Advisory on restriction on the use of montelukast and neuropsychiatric effects
Characteristics of sibutramine-induced adverse events due to adulterated health products
Reminder to verify HLA-B*1502 status in new patients of Asian ancestry before starting carbamazepine treatment
Voluntary withdrawal of Esmya TM (ulipristal acetate) Tablet 5mg in Singapore due to risk of serious liver injury
Risk of drug-induced liver injury associated with the use of pirfenidone
AE Case in Focus: Test Yourself
Reporting vaccine adverse events